journal article·2017-10-03

Antitumor activities on HL-60 human leukemia cell line, molecular docking, and quantum-chemical calculations of some sulfonamide-benzoxazoles

Emine Oksuzoglu, Tugba Ertan-Bolelli, Hatice Can, Mehtap Tarhan, Kamile Ozturk, Ilkay Yildiz

Publisher page

Abstract

We previously synthesized some novel benzoxazole derivatives-containing sulfonamide. In this study, the compounds were investigated for their antitumor activities against the HL-60 human leukemia cells, using the MTT assay. Moreover, quantum chemical calculations using the DFT methods were applied for understanding the difference in antitumor activity. Additionally, molecular docking into active site of the DNA Topo II enzyme was performed on 3QX3. PDB file in order to find out possible mechanism of antitumor effect. According to all obtained results showed that compounds 1b, 1c, and 1d could be potential drug candidates as new antitumor agents, and are promising for cancer therapy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Synthesis and Biological Evaluation · Synthesis and biological activity · Chemical Reaction Mechanisms

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Molecular Biology Division, Department of Biology, Faculty of Science and Letters, Aksaray University, Aksaray, Turkey;

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ankara University, Tandogan, Ankara, Turkey;

Department of Chemistry, Faculty of Basic Sciences, Gebze Technical University, Gebze-Kocaeli, Turkey

Funding

This study was supported by the Scientific Research Project of Aksaray University · and the Scientific Research Project of Ankara University

References (50)

Show source-provided references
1. 10.4172/2161-0444.S1-00110.4172/2161-0444.S1-001 ↗
2. 10.3109/21691401.2016.117069410.3109/21691401.2016.1170694 ↗
3. Akbay A · Arzneim Forsch · 2003 · 53 · 266
4. 10.1016/j.nucmedbio.2010.02.00610.1016/j.nucmedbio.2010.02.006 ↗
5. 10.2174/156801105422236410.2174/1568011054222364 ↗
6. 10.1063/1.46491310.1063/1.464913 ↗
7. 10.1021/jm801566q10.1021/jm801566q ↗
8. 10.1039/b810189b10.1039/b810189b ↗
9. 10.1016/j.ejmech.2012.11.01510.1016/j.ejmech.2012.11.015 ↗
10. 10.1016/j.bmcl.2010.09.05210.1016/j.bmcl.2010.09.052 ↗
11. 2012
12. 10.1007/s11164-013-1464-x10.1007/s11164-013-1464-x ↗
13. 10.1016/j.ejmech.2008.04.00110.1016/j.ejmech.2008.04.001 ↗
14. 10.1002/cmdc.20140001010.1002/cmdc.201400010 ↗
15. 10.1007/s00044-015-1499-110.1007/s00044-015-1499-1 ↗
16. Fleming I. 1976. Frontier Orbitals and Organic Chemical Reactions. Trowbridge, Wiltshire: Wiley Redwood Books, pp. 1.
17. Gautam MK. · Int J ChemTech Res · 2012 · 4 · 640
18. Gaussian 09, Revision D.01, Frisch, Trucks GV, Schlegel HB, Scuseria GE, et al. 2009. Wallingford, CT: Gaussian Inc.
19. Jagani H · Artif Cells Nanomed Biotechnol · 2016 · 44 · 121210.3109/21691401.2015.1019668 ↗
20. 10.1016/j.bmc.2010.05.00710.1016/j.bmc.2010.05.007 ↗
21. 10.1016/S0968-0896(97)10021-910.1016/S0968-0896(97)10021-9 ↗
22. 10.1016/j.ejmech.2008.06.02710.1016/j.ejmech.2008.06.027 ↗
23. 10.1016/S0928-0987(00)00114-710.1016/S0928-0987(00)00114-7 ↗
24. 10.1002/ijc.2179210.1002/ijc.21792 ↗
25. 10.1103/PhysRevB.37.78510.1103/PhysRevB.37.785 ↗
26. 10.1517/13543776.16.4.43110.1517/13543776.16.4.431 ↗
27. 10.1016/0022-1759(83)90303-410.1016/0022-1759(83)90303-4 ↗
28. 10.1038/nrc260710.1038/nrc2607 ↗
29. 10.1080/1475636070134251610.1080/14756360701342516 ↗
30. 10.1016/j.bmc.2012.10.01010.1016/j.bmc.2012.10.010 ↗
31. Oren I · Arzneim Forsch/Drug Res · 1997 · 47 · 1393
32. 10.1016/S0928-0987(98)00017-710.1016/S0928-0987(98)00017-7 ↗
33. 10.1021/jm990263810.1021/jm9902638 ↗
34. 10.1016/j.arabjc.2011.12.00610.1016/j.arabjc.2011.12.006 ↗
35. 10.1016/j.bbrc.2004.03.09310.1016/j.bbrc.2004.03.093 ↗
36. 10.1073/pnas.030852010110.1073/pnas.0308520101 ↗
37. 10.1016/j.ejmech.2005.03.02310.1016/j.ejmech.2005.03.023 ↗
38. 10.7164/antibiotics.54.10210.7164/antibiotics.54.102 ↗
39. 10.1016/j.ejmech.2011.03.01710.1016/j.ejmech.2011.03.017 ↗
40. Schisselbauer JC · Cancer Res · 1990 · 50 · 3562
41. 10.1016/j.ejmech.2014.02.05010.1016/j.ejmech.2014.02.050 ↗
42. 10.1021/jm960095910.1021/jm9600959 ↗
43. 10.3109/1040923920908256610.3109/10409239209082566 ↗
44. Varga A · In Vivo · 2005 · 19 · 1087
45. Waxman DJ. · Cancer Res · 1990 · 50 · 6449
46. 10.1126/science.120411710.1126/science.1204117 ↗
47. 10.1002/jcc.1030610.1002/jcc.10306 ↗
48. 10.3390/molecules1701087310.3390/molecules17010873 ↗
49. 10.1002/ardp.20030085110.1002/ardp.200300851 ↗
50. 10.1016/j.ejmech.2003.11.01410.1016/j.ejmech.2003.11.014 ↗